ArticleG3 (Bethesda, Md.)2026
Zasp52 in Drosophila melanogaster indirect flight muscles can serve as a model system to investigate the function of clinical variants causing myopathies.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The sarcomere is the basic contractile unit of muscle fibers, bordered by Z-discs. In Drosophila, Z-disc structure and maintenance rely on actinin, and the Z-band alternatively spliced PDZ-motif protein 52 (Zasp52), a member of the Alp/Enigma family. Zasp52 has been shown to bind actin, actinin, and itself, but its full range of functions remains unclear, as a null mutant has not been previously analyzed. To address this, we generated a CRISPR-based null mutant of Zasp52, deleting most of the ∼50 kb locus. Null mutants are viable but flightless and display severe defects in indirect flight muscle architecture. To test redundancy, we also analyzed a double null of Zasp52 and Zasp67, the latter one being a Zasp member restricted to flight muscles. Both single and double mutants exhibit damaged myofibrils, with the double mutant showing a more severe collapse of sarcomere organization. Given the clinical importance of LIM domain-binding 3 (LDB3) mutations, the human ortholog of Zasp52, we next modeled a pathogenic variant. In humans, the P615L mutation in LDB3 has been linked to cardiomyopathy and skeletal myopathy. We engineered the orthologous substitution, Zasp52-P607L, and expressed it in Drosophila indirect flight muscles. The variant produced enlarged sarcomeres and enhanced binding, consistent with a gain-of-function disease phenotype. Together, these findings indicate that Drosophila indirect flight muscles can be used as a system to dissect Zasp function, reveal redundancy in Z-disc assembly, and provide mechanistic insight into how conserved mutations contribute to human myopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.